Bicara Therapeutics Inc (BCAX)

11:22 AM

Bicara Therapeutics Inc stock hits all-time high at 29.92 USD - Investing.com

11:22 AM

Jul 03, 2026

Price to earnings forward of Bicara Therapeutics Inc. – NASDAQ:BCAX - TradingView

Jul 03, 2026

Jul 02, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 02, 2026

Jul 01, 2026

Citizens upgrades Bicara Therapeutics stock price target on CRC data - Investing.com UK

Jul 01, 2026

Jul 01, 2026

Citizens upgrades Bicara Therapeutics stock price target on CRC data By Investing.com - Investing.com South Africa

Jul 01, 2026

Jun 30, 2026

BICARA THERAPEUTICS INC (BCAX) Stock Chart - ChartMill

Jun 30, 2026

Jun 29, 2026

Bicara Therapeutics stock hits 52-week high at 27.98 USD - Investing.com

Jun 29, 2026

Jun 29, 2026

Bicara Therapeutics stock hits 52-week high at 27.98 USD By Investing.com - Investing.com Australia

Jun 29, 2026

Jun 29, 2026

BCAXBicara Therapeutics Inc Volatility & Greeks - Finviz

Jun 29, 2026

Jun 28, 2026

Bicara Therapeutics Inc. Actuals & Estimates (BOATS:BCAX) - TradingView

Jun 28, 2026

Jun 26, 2026

Bicara Therapeutics Inc. Actuals & Estimates (NASDAQ:BCAX) - TradingView

Jun 26, 2026

Jun 25, 2026

Form 144 BICARA THERAPEUTICS INC. For: 25 June By Investing.com - Investing.com Nigeria

Jun 25, 2026

Jun 25, 2026

BCAX (NASDAQ: BCAX) affiliate to offer 50,000 shares after option exercise - Stock Titan

Jun 25, 2026

Jun 25, 2026

BCAX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Bicara Therapeutics Inc (BCAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026

Jun 22, 2026

Bicara Therapeutics stock hits 52-week high at 24.29 USD - Investing.com

Jun 22, 2026

Jun 22, 2026

Bicara Therapeutics stock hits 52-week high at 24.29 USD By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors? - AOL.com

Jun 22, 2026

Jun 19, 2026

Bicara Therapeutics Inc (BCAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 19, 2026

Jun 19, 2026

Bicara Therapeutics Inc (BCAX) Institutional Confidence - TradingKey

Jun 19, 2026

Jun 19, 2026

Bicara Therapeutics Inc (BCAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 19, 2026

Jun 19, 2026

Bicara Therapeutics Inc (BCAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 19, 2026

Jun 19, 2026

Bicara Therapeutics Inc (BCAX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 19, 2026

Jun 19, 2026

[Bicara Therapeutics (BCAX) Rises 1.35% as Stock Holds Above Key SupportTICK Divergence - Město Břeclav

Jun 19, 2026

Jun 17, 2026

Bicara Therapeutics Inc (BCAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Bicara Therapeutics Inc (BCAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

Bicara Therapeutics Inc (BCAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Bicara Therapeutics Inc. appoints Chris Sarchi as Chief Commercial Officer to drive commercial growth - Traders Union

Jun 17, 2026

Jun 14, 2026

Bicara Therapeutics CEO Sells 15,000 Shares: Insider Transaction Under ScrutinyDividend Earnings Report - newsline.com

Jun 14, 2026

Jun 13, 2026

What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors? - The Motley Fool

Jun 13, 2026

Jun 12, 2026

Bicara Therapeutics Inc. joins ACS CAN in efforts to shape evidence-based cancer policies - Traders Union

Jun 12, 2026

Jun 10, 2026

Bicara Therapeutics Holds 2026 Annual Stockholder Meeting - TipRanks

Jun 10, 2026

Jun 10, 2026

[Form 4] Bicara Therapeutics Inc. Insider Trading Activity - Stock Titan

Jun 10, 2026

Jun 10, 2026

Bicara Therapeutics (BCAX) director receives 19,475-share option tied to RA Capital - Stock Titan

Jun 10, 2026

Jun 10, 2026

[8-K] Bicara Therapeutics Inc. Reports Material Event - Stock Titan

Jun 10, 2026

Jun 08, 2026

Bicara Therapeutics Inc. presents three year Phase 1b results for ficerafusp alfa combination in HPV negative HNSCC - Traders Union

Jun 08, 2026

Jun 07, 2026

BCAX Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Clinical Pipeline ProgressDebt Analysis Report - newsline.com

Jun 07, 2026

Jun 05, 2026

Bicara Therapeutics (BCAX) Edges Lower, Tests Key Support LevelsCumulative Volume - newsline.com

Jun 05, 2026

Jun 04, 2026

BCAX Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre‑Revenue Biotech’s R&D SpendingFinancial Data - newsline.com

Jun 04, 2026

Jun 03, 2026

Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Bicara Therapeutics Inc. (BCAX) - The Globe and Mail

Jun 03, 2026

Jun 02, 2026

Cantor Fitzgerald reiterates Bicara Therapeutics stock rating - Investing.com

Jun 02, 2026

Jun 02, 2026

Cantor Fitzgerald reiterates Bicara Therapeutics stock rating By Investing.com - Investing.com India

Jun 02, 2026

Jun 01, 2026

Bicara (BCAX) Q4 2025 Earnings Transcript - AOL.com

Jun 01, 2026